Published on 5/10/2005 in the Prospect News Convertibles Daily.
New Issue: ABN Amro sells $1.275 million 10% reverse exchangeables linked to Biogen Idec
New York, May 10 - ABN Amro Bank NV priced $1.275 million of one-year 10% reverse exchangeable notes linked to Biogen Idec Inc. common stock, according to a 424B3 filing with the Securities and Exchange Commission.
Issuer: | ABN Amro Bank NV
|
Issue: | Reverse exchangeable senior medium-term notes
|
Underlying stock: | Biogen Idec Inc.
|
Amount: | $1.275 million
|
Maturity: | May 11, 2006
|
Coupon: | 10%
|
Price: | Par
|
Payout at maturity: | Smaller of par in cash or 26.008 shares of Biogen Idec stock
|
Exchange ratio: | 26.008
|
Exchange price: | $38.45 (initial level of Biogen Idec stock)
|
Call: | Non-callable
|
Pricing date: | May 6
|
Settlement date: | May 11
|
Lead manager: | ABN Amro Financial Services
|
Distribution: | Off shelf
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.